Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Environ Sci Pollut Res Int ; 30(11): 31395-31407, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-36449235

RESUMO

Excessive serum copper has multiple effects on human health, while the association between copper and obesity remains unclear. The objective of this study is to examine the associations of serum copper concentrations with obesity and adiposity measures, including body fat composition and distribution among adults in the USA. This analysis utilized data from the National Health and Nutrition Examination Survey (NHANES) (2011-2016). A total of 7285 adults aged 18 years or older who had serum copper measures were included in this cross-sectional study. Multi-linear regression and logistic regression were used to estimate the independent risky effect of copper on fat deposition and all-cause mortality. Moreover, these associations were analyzed in stratification analysis by gender, age, and physical activity (PA). Generally, we found that participants who were females, non-Hispanic Black, or with inactive PA tended to have a higher serum level of copper. In addition, we observed positive associations between serum copper and adiposity measurements. Furthermore, a serum copper level higher than 133.9 µg/dL was a risk factor for all-cause mortality, which doubled the odds ratio of all-cause mortality compared to the normal serum copper level. Serum copper was positively associated with fat deposition of whole body and regional parts, and all-cause mortality. Furthermore, the effects of copper on fat distribution were also significant and could be modified by age, gender, and PA.


Assuntos
Cobre , Obesidade , Adulto , Feminino , Humanos , Masculino , Inquéritos Nutricionais , Estudos Transversais , Índice de Massa Corporal , Circunferência da Cintura , Obesidade/epidemiologia , Adiposidade
2.
Nanoscale Res Lett ; 14(1): 211, 2019 Jun 21.
Artigo em Inglês | MEDLINE | ID: mdl-31227943

RESUMO

A subcellular organelle-targeted delivery of anti-cancer drugs is a promising strategy to maximize the anti-cancer effects and minimize the adverse effects. Herein, we prepared a mitochondria-targeted drug delivery nanoplatform based on IR780 iodide (IR780) and titanium disulfide (TiS2) nanosheets. Due to the large specific surface area of TiS2 nanosheets, the nanoplatform could highly load anti-cancer drug resveratrol (RV). The as-prepared nanocomposite (IR780-TiS2/RV) was used for an efficacious photothermal-triggered tumor chemotherapy. IR780-TiS2/RV showed satisfactory stability and biocompatibility, and the loading ratio of RV and IR780 was about 112% and 56%, respectively. Upon the near-infrared (NIR) irradiation, the heat generated by IR780-TiS2/RV could trigger the RV release. Due to the conjugation with the mitochondria-specific IR780, IR780-TiS2/RV could target and accumulate in mitochondria and release RV when triggered by NIR to decrease the mitochondrial membrane potential, rapidly induce the upregulation of key intrinsic apoptotic factors such as cytochrome c, and initiate the caspase cascade, thereby achieving the chemotherapeutic effect. The IR780-TiS2/RV nanocomposite was demonstrated to have a high anti-tumor efficacy in vitro and in vivo as well as no remarkable tissue toxicity. We believe our study demonstrates that the NIR-triggered IR780-TiS2/RV nanoplatform could be a promising chemotherapeutic agent in clinical practice.

3.
Chem Commun (Camb) ; 54(58): 8112-8115, 2018 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-29972151

RESUMO

A novel lithium ion/oxygen hybrid battery system is proposed that uses the advantages and minimizes the disadvantages of both lithium-ion batteries (LIBs) and lithium-oxygen batteries (LOBs). In it, the LOB-part plays range-extending and high-power output roles, while using the discharge-priority of the LIB-part is suggested to compensate the cycling-life shortcomings of the LOB-part.

4.
Zhongguo Ying Yong Sheng Li Xue Za Zhi ; 33(1): 22-25, 2017 Jan 08.
Artigo em Chinês | MEDLINE | ID: mdl-29926602

RESUMO

OBJECTIVE: To observe the effects of arecoline on lipid metabolism in 3T3-L1 adipocytes and explore its possible mechanisms. METHODS: 3T3-L1 pre-adipocytes were induced into adipocytes with the classic "cocktail" method, subsequently, adipocytes were treated with arecoline at the concentrations of 0, 25, 50 and 100 µmol/L for 72 hours. After 72 hours, cell vability was measured with MTT method, lipid droplet accumulation in the cytoplasm was observed with oil red O staining, the protein expression of fatty acid synthase (FAS), adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) were detected by Western blot assay. RESULTS: There were a large number of lipid droplets in the cytoplasm in the differentiated 3T3-L1 adipocytes. MTT results showed that 0~100 µmol/L arecoline had no significant effect on cell vability; oil red O staining found arecoline reduced lipid amount in 3T3-L1 adipocytes; Western blot results showed that compared with 0 µmol/L arecoline group (the control group), arecoline significantly reduced the protein level of FAS and increased the protein levels of ATGL and HSL, and 50 µmol/L arecoline group was the most significant. CONCLUSIONS: Arecoline significantly increased lipolysis of 3T3-L1 adipocyte, which might be associated with decreased the FAS expression of key enzyme of lipid synthesis and increased the ATGL and HSL expression of key enzyme of adipolysis.


Assuntos
Adipócitos/efeitos dos fármacos , Arecolina/farmacologia , Metabolismo dos Lipídeos , Lipólise , Células 3T3-L1 , Adipócitos/metabolismo , Animais , Ácido Graxo Sintases/metabolismo , Lipase/metabolismo , Camundongos , Esterol Esterase/metabolismo
5.
Zhongguo Ying Yong Sheng Li Xue Za Zhi ; 33(4): 323-328, 2017 Apr 08.
Artigo em Chinês | MEDLINE | ID: mdl-29926637

RESUMO

OBJECTIVE: To observe the effects of dihydromyricetin(DHM) on cognitive dysfunction and expression of brain derived neurotrophic factor(BDNF) protein in hippocampus of type 2 diabetic mice(T2DM). METHODS: Forty C57BL/6J mice were randomly divided into two groups, normal control group (n=8):normal diet feeding; T2DM model group (n=32):high-glucose and high-fat combined with 100 mg/kg streptozocin(STZ) treatment (five mice died during modeling and three failed). Twenty-four diabetic mice were modeled successfully and divided into three groups (T2DM group, T2DM+L-DHM group and T2DM+H-DHM group). Three groups mice were fed with high-glucose and high-fat diet, and treated with equal volume of normal saline, 125 mg/(kg·d) DHM or 250 mg/(kg·d) DHM for 16 weeks respectively. The control mice were fed with normal diet and treated with equal volume of saline (once a day, gavage) for 16 weeks. After 16 weeks, the body weight and fasting blood glucose were measured, intraperitoneal glucose tolerance test and related behavioral experiment were performed. Finally, the expression of BDNF protein in hippocampus of mice was detected by Western blot. RESULTS: The model of type 2 diabetes mellitus was established successfully with high-glucose and high-fat combined with 100 mg/kg STZ. After 16 weeks, the body weight of T2DM group was significantly decreased, the fasting blood glucose was significantly increased and the glucose tolerance was significantly abnormal compared with the normal control group. Compared with T2DM group, the body weight of T2DM+DHM groups mice was increased, while the levels of fasting blood glucose were decreased. And H-DHM could significantly improve the abnormal glucose tolerance of T2DM mice. Behavior test results showed that the ability of learning and memory of T2DM mice was significant decreased compared with control group, but these phenomena were improved in T2DM+DHM groups mice, and T2DM+H-DHM group was more obvious. Western blot analysis showed that the expression of BDNF protein in hippocampus of T2DM group was significantly lower than that of control group, while T2DM+DHM group was significant increased compared with T2DM mice. CONCLUSIONS: Dihydromyricetin can improve the cognitive dysfunction in type 2 diabetic mice. The mechanism may be through hypoglycemic effect and activation of BDNF protein expression in hippocampus.


Assuntos
Fator Neurotrófico Derivado do Encéfalo/metabolismo , Disfunção Cognitiva/tratamento farmacológico , Diabetes Mellitus Tipo 2/complicações , Flavonóis/farmacologia , Hipocampo/efeitos dos fármacos , Animais , Glicemia , Diabetes Mellitus Experimental/complicações , Hipocampo/metabolismo , Aprendizagem/efeitos dos fármacos , Memória/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL
6.
Infect Genet Evol ; 39: 330-335, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26861620

RESUMO

Giardia duodenalis is a gastrointestinal protozoan that infects sheep. It is a well-known zoonotic pathogen and sheep have been implicated as a source of human infection. However, there have been few studies of its potential threat to public health in China. We used a multilocus analysis of the beta-giardin (bg), glutamate dehydrogenase (gdh), and triose phosphate isomerase (tpi) genes to examine the occurrence and genotype distribution of G. duodenalis in sheep in China. In total, 716 fresh faecal specimens, including 89 from pre-weaned lambs (<3 months old) and 627 from post-weaned sheep (>3 months old) from nine intensive sheep farms in Henan Province, China, were examined for Giardia cysts with microscopy. Of these specimens, 6.65% (47/716; 99% CI: 6.2%-6.92%) from five farms were positive for G. duodenalis. The infection rate was significantly higher in pre-weaned lambs than in post-weaned sheep (12.36% versus 5.74%, respectively; P<0.05). Infection rates ranged from 2.8% to 17.2% on the G. duodenalis-positive farms. All G. duodenalis-positive samples were assayed with PCR followed by sequencing at the three gene loci investigated in this study. As a result, two assemblages were detected: assemblage A (n=5) and assemblage E (n=31), with some mixed E and A infections (n=3). The ratios of assemblage A to assemblage E on the different successfully sequenced G. duodenalis-positive farms were 0:1, 3:14, 1:4, and 1:12. Two new tpi sequences and one new gdh sequence were identified. Multilocus genotyping yielded seven multilocus genotypes (MLGs): one new assemblage A MLG and six assemblage E MLGs. In the phylogenetic analysis, the assemblage A MLG was more closely related to AI than to AII or AIII. The detection of G. duodenalis assemblage A in sheep has public health implications, although G. duodenalis assemblage E was predominant. The data provide basic information for control of giardiasis in human and sheep in Henan province, central China.


Assuntos
Genótipo , Giardia lamblia/genética , Giardíase/veterinária , Doenças dos Ovinos/epidemiologia , Doenças dos Ovinos/parasitologia , Animais , China/epidemiologia , Genes de Protozoários , Giardia lamblia/classificação , Humanos , Tipagem de Sequências Multilocus , Filogenia , Prevalência , Análise de Sequência de DNA , Ovinos
7.
Zhongguo Ying Yong Sheng Li Xue Za Zhi ; 32(4): 370-372, 2016 Apr 08.
Artigo em Chinês | MEDLINE | ID: mdl-29931964

RESUMO

OBJECTIVE: To observe the effects of arecoline on proliferation and apoptosis of MCF-7 human breast cancer cells and to ex-plore its possible mechanism. METHODS: Human breast cancer MCF-7 cells were treated with arecoline at the concentrations of 0,10,30,50, 100,300,500µmol/L, the cell proliferation were detected by MTT assay, cell apoptosis were analyzed by Hoechst 33342 staining and flow cy-tometry, the protein expression of Bax,Bcl-2 and P53 were detected by Western blot. RESULTS: Low concentration(0,10,30, 50 µmol/L) arecoline had no effect on the proliferation and apoptosis of MCF-7. However, high concentration(100,300,500µmol/L) arecoline inhibited proliferation and induced apoptosis of MCF-7 cells in a concentration-dependent manner, arecoline also significantly increased P53 and Bax protein expression and decreased Bcl-2 protein expression. CONCLUSIONS: High concentration arecoline inhibited the proliferation and induced the apoptosis of MCF-7 cells, the mechanism was probably corrected with increasing P53 and Bax protein expression and decreasing Bcl-2 pro-tein expression.


Assuntos
Apoptose/efeitos dos fármacos , Arecolina/farmacologia , Proliferação de Células/efeitos dos fármacos , Neoplasias da Mama , Humanos , Células MCF-7 , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína Supressora de Tumor p53/metabolismo , Proteína X Associada a bcl-2/metabolismo
8.
Zhongguo Ying Yong Sheng Li Xue Za Zhi ; 30(3): 208-12, 2014 May.
Artigo em Chinês | MEDLINE | ID: mdl-25244782

RESUMO

OBJECTIVE: To explore the effects of arecoline on hepatic insulin resistance in type 2 diabetes rats and to elucidate its possible mechanism. METHODS: Forty five Wistar rats were fed with high fructose diet for 12 weeks to induce type 2 diabetic rat model. rats were randomly divided into 5 groups (n = 8): control group, model group and model group were treated with different dose (0, 0.5, 1, 5 mg/kg) of arecoline. After 4 weeks, the fasting blood glucose, blood lipid and insulin level measured , mRNA expression of liver constitutive androstane receptor (CAR), pregnane X receptor (PXR), glucose-6-phosphatase (G6Pase), phosphoenolpyruvate carboxykinase (PEPCK), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) were detected by reverse transcription polymerase chain reaction (RT-PCR), the protein expression of p-AKT and glucose transporter4 (GLUT4) were detected by Western blot. RESULTS: 1.5 mg/kg arecoline could significantly decrease the level of fasting blood glucose, blood lipid, blood insulin level and liver G6Pase, PEPCK, IL-6, TNF-alpha mRNA level in type 2 diabetes rats. 1.5 mg/kg arecoline also could significantly increase CAR, PXR mRNA level and p-AKT and GLUT4 protein expression. CONCLUSION: Arecoline improved hepatic insulin resistance in type 2 diabetes rats by increasing the mRNA levels of CAR and PXR leading to the creased glucose metabolism and inflammation related genes expression.


Assuntos
Arecolina/farmacologia , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Resistência à Insulina , Fígado/efeitos dos fármacos , Animais , Receptor Constitutivo de Androstano , Transportador de Glucose Tipo 4/metabolismo , Glucose-6-Fosfatase/metabolismo , Interleucina-6/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Fígado/metabolismo , Masculino , Fosfoenolpiruvato Carboxiquinase (GTP)/metabolismo , Receptor de Pregnano X , Proteínas Proto-Oncogênicas c-akt/metabolismo , Ratos , Ratos Wistar , Receptores Citoplasmáticos e Nucleares/metabolismo , Receptores de Esteroides/metabolismo , Fator de Necrose Tumoral alfa/metabolismo
9.
J Arthroplasty ; 26(3): 419-26, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20851564

RESUMO

This systematic review compared 2 treatments for hip disease in active young patients: modern metal-on-metal total hip resurfacing and standard total hip arthroplasty. We conducted a literature search to identify relevant randomized and clinical controlled trials and included 968 patients from 4 trials in our analysis. Our results indicated increased rates of revision, femoral neck fractures, and component loosening among patients who received modern metal-on-metal hip resurfacing. No significant differences in the rates of mortality, dislocation, or deep hip joint infection were found between treatment groups. Hip function scores were similar between the 2 groups, but the resurfacing group showed higher activity levels. These results have provided insufficient evidence to determine whether modern metal-on-metal total hip resurfacing offers clinical advantages over standard total hip arthroplasty.


Assuntos
Artroplastia de Quadril/métodos , Prótese de Quadril , Metais , Qualidade de Vida , Adulto , Fatores Etários , Articulação do Quadril/fisiologia , Articulação do Quadril/cirurgia , Humanos , Artropatias/fisiopatologia , Artropatias/cirurgia , Pessoa de Meia-Idade , Resultado do Tratamento
10.
Artigo em Chinês | MEDLINE | ID: mdl-22295507

RESUMO

OBJECTIVE: To explore miRNA expression change of differentiation of mice marrow mesenchymal stem cells (MSCs) into adipocytes, which lay the foundation for further studies on molecular mechanism of miRNA regulating the differentiation of MSCs into adipocytes. METHODS: C57BL/6 mice MSCs were isolated, cultured through the whole bone marrow method, amplified by the differential adherent method. Cell growth was observed by morphology and the expression of superficial antigen CD29, CD44, CD34 were detected through immunohistochemistry. MSCs was induced to differentiation into adipocytes with adipocyte differentiation medium, and adipogenic differentiation of MSCs was analyzed by oil Red O staining. MicroRNA microarray was used to investigate the differentially expressed miRNAs in MSCs and adipocytes. RESULTS: (1) The fifth passage of MSCs had high purity under an inverted m icroscope. Immunohistochemistry staining showed that CD29, CD44 were positive and CD34 was negative in more than 90% MSCs. There were a large number of lipid droplets in cytoplasm after MSCs were induced with adipocyte differentiation medium, Oil O staining was positive. (2) The microarray experiment showed that 75 differentially expressed miRNAs were obtained in adipocytes compared with MSCs, 20 up-regulated and 55 down-regulated miRNAs were observed among them. CONCLUSION: There was a expression change of miRNA of differentiation of MSCs into adipocytes, some miRNAs might play important roles in MSCs adipogenic differentiation.


Assuntos
Adipócitos/citologia , Células da Medula Óssea/citologia , Diferenciação Celular/fisiologia , Células-Tronco Mesenquimais/citologia , MicroRNAs/metabolismo , Animais , Células Cultivadas , Masculino , Camundongos , Camundongos Endogâmicos C57BL , MicroRNAs/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA